ConvaTec Group (CTEC) Given Neutral Rating at Citigroup
A number of other research analysts have also recently issued reports on CTEC. Numis Securities reiterated a hold rating and set a GBX 180 ($2.49) price objective on shares of ConvaTec Group in a research note on Thursday. Peel Hunt reiterated a hold rating and set a GBX 250 ($3.45) price objective on shares of ConvaTec Group in a research note on Thursday. Finally, Deutsche Bank restated a sell rating and issued a GBX 180 ($2.49) price target on shares of ConvaTec Group in a research note on Friday, December 1st. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company’s stock. The stock has an average rating of Hold and a consensus target price of GBX 244.67 ($3.38).
ConvaTec Group (CTEC) opened at GBX 215.30 ($2.97) on Friday. The stock has a market capitalization of $4,200.00 and a price-to-earnings ratio of 3,588.33. ConvaTec Group has a one year low of GBX 181.40 ($2.51) and a one year high of GBX 349.10 ($4.82).
In other ConvaTec Group news, insider Ros Rivaz purchased 4,821 shares of the firm’s stock in a transaction dated Wednesday, December 6th. The stock was purchased at an average price of GBX 206 ($2.85) per share, for a total transaction of £9,931.26 ($13,721.00).
TRADEMARK VIOLATION WARNING: This story was originally reported by Watch List News and is the property of of Watch List News. If you are viewing this story on another domain, it was illegally copied and republished in violation of United States and international copyright & trademark law. The legal version of this story can be accessed at https://www.watchlistnews.com/convatec-group-ctec-given-neutral-rating-at-citigroup/1875060.html.
ConvaTec Group Company Profile
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.